AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Kristoferitsch, W Seeldrayers, P Kyriallis, K Brochet, B Confavreux, C Clanet, M Cesaro, P Defer, G Edan, G Lyon-Caen, O Pelletier, J Rumbach, L Roullet, E Vermersch, P Dengler, R Zschenderlein, R Storch-Hagenlocher, B Sailer, M Hohlfeld, R Kunze, KP Heesen, C Bamborschke, P Grunwald, F Hartung, HP Rieckmann, P DeKeyser, J Montalban, X Fernandez, U Arbizu, T Sandberg, M Kappos, L Bates, D Campbell, MJ Capildeo, R Compston, A McLellan, DL Wroe, S Young, C Clanet, M Hartung, HP Hohlfeld, R Kappos, L Radue, EW Rieckmann, P Sandberg, M Polman, C Kesselring, J Thompson, A Wekerle, H Whitehead, J Bains, H Butler, E Kooijmans-Coutinho, M McAllister, A Simonian, N White, K Anderson, D Liddiard, S Keane, R
Citation: W. Kristoferitsch et al., Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data, MULT SCLER, 7(3), 2001, pp. 179-183

Authors: Prass, K Bruck, W Schroder, NWJ Bender, A Prass, M Wolf, T Van der Knapp, MS Zschenderlein, R
Citation: K. Prass et al., Adult-onset leukoencephalopathy with vanishing white matter presenting with dementia, ANN NEUROL, 50(5), 2001, pp. 665-668

Authors: Aktas, O Waiczies, S Grieger, U Wendling, U Zschenderlein, R Zipp, F
Citation: O. Aktas et al., Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis, J NEUROIMM, 114(1-2), 2001, pp. 160-167

Authors: Lunemann, JD Zarmas, S Priem, S Franz, J Zschenderlein, R Aberer, E Klein, R Schouls, L Burmester, GR Krause, A
Citation: Jd. Lunemann et al., Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of lyme borreliosis (vol 39, pg 1130, 2001), J CLIN MICR, 39(5), 2001, pp. 2041-2041

Authors: Lunemann, JD Zarmas, S Priem, S Franz, J Zschenderlein, R Aberer, E Klein, R Schouls, L Burmester, GR Krause, A
Citation: Jd. Lunemann et al., Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis, J CLIN MICR, 39(3), 2001, pp. 1130-1133

Authors: Lunemann, JD Aktas, O Gniadek, P Zschenderlein, R Zipp, F
Citation: Jd. Lunemann et al., Downregulation of transforming growth factor-beta 1 in interferon-beta 1a-treated MS patients, NEUROLOGY, 57(6), 2001, pp. 1132-1134

Authors: Buttner, U Chofflon, M Hess, K Kappos, L Kesselring, J Ludin, HP Schluep, M Vaney, C Baumhackl, U Berger, T Deisenhammer, F Freimuller, M Hartung, HP Kollegger, H Kristoferitsch, W Lassmann, H Markut, H Vass, K Altenkirch, H Boese, J Gass, A Gehlen, W Goebels, N Haas, J Haferkamp, G Heidenreich, F Heitmann, R Hemmer, B Hohlfeld, R Janzen, RWC Jugelt, E Kolmel, W Konig, N Kowitzsch, K Manegold, U Melms, A Mertin, J Petereit, HF Pette, M Pohlau, D Poser, S Sailer, M Schmidt, S Schock, G Schulz, M Seidel, D Stangel, M Stark, E Stoll, G Weinrich, W Wietholter, H Zettl, UK Zipp, F Zschenderlein, R Bayas, A Chan, A Flachenecker, P Gold, R Grauer, O Jung, S Kallmann, B Leussink, V Maurer, M Rieckmann, P Toyka, KV Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157

Authors: Holtkamp, M Zschenderlein, R Bruck, W Weber, JR
Citation: M. Holtkamp et al., Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis, ACT NEUROP, 101(5), 2001, pp. 529-531

Authors: Wendling, U Aktas, O Schmierer, K Zschenderlein, R Zipp, F
Citation: U. Wendling et al., Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells - implications for multiple sclerosis, J NEUROIMM, 103(1), 2000, pp. 69-75

Authors: Zipp, F Beyer, M Gelderblom, H Wernet, D Zschenderlein, R Weller, M
Citation: F. Zipp et al., No induction of apoptosis by IFN-beta in human antigen-specific T cells, NEUROLOGY, 54(2), 2000, pp. 485-487

Authors: Aktas, O Wendling, U Zschenderlein, R Zipp, F
Citation: O. Aktas et al., Apoptosis in multiple sclerosis - etiopathogenetic relevance and perspectives for new therapeutic strategies, NERVENARZT, 71(10), 2000, pp. 767-773

Authors: Knirsch, UI Bachus, R Gosztonyi, G Zschenderlein, R Ludolph, AC
Citation: Ui. Knirsch et al., Clinicopathological study of atypical motor neuron disease with vertical gaze palsy and ballism, ACT NEUROP, 100(3), 2000, pp. 342-346

Authors: Buttner, U Chofflon, M Hess, K Kappos, L Kesselring, J Ludin, H Rihs, F Schluep, M Vaney, C Baumhackl, U Berger, T Freimuller, O Hartung, HP Kollegger, W Kristoferitsch, W Vass, K Lassmann, H Markut, S Altenkirch, H Boese, J Gehlen, W Goebels, N Gold, R Haas, J Haferkamp, G Heidenreic, F Heitmann, R Hohlfeld, R Jugelt, E Kolmel, H Konig, N Lowitzsch, K Manegold, U Mertin, J Pette, M Poser, S Sailer, J Schack, G Schulz, M Seidel, D Stark, E Stoll, G Weinrich, W Wietholter, H Zettl, U Zipp, F Zschenderlein, R Rieckmann, P Toyka, KV Chan, A Bayas, A Maurer, M Jung, S Gold, R Weilbach, F Cursiefen, S Flachenecker, P Rieckmann, P
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis, NERVENARZT, 70(4), 1999, pp. 371-386
Risultati: 1-13 |